Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: Implications for atherogenesis

Microbes and Infection

Volumn 6, Issue 12, 2004, Pages 1056-1062

  Vliegen, Inge ^a   Duijvestijn, Adrian ^b   Stassen, Frank ^a   Bruggeman, Cathrien ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Cytomegalovirus; Immune activation; Inflammation; Macrophages

Indexed keywords

APOLIPOPROTEIN E; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THIOGLYCOLIC ACID; VIRUS RNA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; IMMUNE RESPONSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; CELL DIFFERENTIATION; CYTOKINES; HERPESVIRIDAE INFECTIONS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MUROMEGALOVIRUS;

CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 4544370768     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.05.020     Document Type: Article

References (42)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
2. Pentikainen M.O., Oorni K., Ala Korpela M., and Kovanen P.T. Modified LDL-trigger of atherosclerosis and inflammation in the arterial intima J. Intern. Med. 247 2000 359 370
3. Saadeddin S.M., Habbab M.A., and Ferns G.A. Markers of inflammation and coronary artery disease Med. Sci. Monit. 8 2002 RA5 RA12
4. Pietila K., and Nikkari T. Role of the arterial smooth muscle cell in the pathogenesis of atherosclerosis Med. Biol. 61 1983 31 44
5. Epstein S.E., Zhou Y.F., and Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms Circulation 100 1999 e20 e28
6. Kol A., and Libby P. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations Trends Cardiovasc. Med. 8 1998 191 199
7. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree Arterioscler. Thromb. 14 1994 133 140
8. Hsich E., Zhou Y.F., Paigen B., Johnson T.M., Burnett M.S., and Epstein S.E. Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein E knockout mice Atherosclerosis 156 2001 23 28
9. Burnett M.S., Gaydos C.A., and Madico G.E. Atherosclerosis in apoE knockout mice infected with multiple pathogens J. Infect. Dis. 183 2001 226 231
10. Vliegen I., Duijvestijn A., Grauls G., Herngreen S., Bruggeman C., and Stassen F. Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation Microbes Infect. 6 2004 17 24
11. Smith P.D., Saini S.S., Raffeld M., Manischewitz J.F., and Wahl S.M. Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages J. Clin. Invest. 90 1992 1642 1648
12. Iwamoto G.K., Monick M.M., Clark B.D., Auron P.E., Stinski M.F., and Hunninghake G.W. Modulation of interleukin-1 beta gene expression by the immediate early genes of human cytomegalovirus J. Clin. Invest. 85 1990 1853 1857
13. Pulliam L., Moore D., and West D.C. Human cytomegalovirus induces IL-6 and TNF-alpha from macrophages and microglial cells: possible role in neurotoxicity J. Neurovirol. 1 1995 219 227
14. Hansson G.K. Immune mechanisms in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 21 2001 1876 1890
15. Hamano S., Yoshida H., and Takimoto H. Role of macrophages in acute murine cytomegalovirus infection Microbiol. Immunol. 42 1998 607 616
16. Le Roy E., Baron M., and Faigle W. Infection of APC by human cytomegalovirus controlled through recognition of endogenous nuclear immediate early protein 1 by specific CD4(+) T lymphocytes J. Immunol. 169 2002 1293 1301
17. Vliegen I., Stassen F., Grauls G., Blok R., and Bruggeman C. MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice J. Clin. Virol. 25 Suppl. 2 2002 159
18. Vliegen I., Herngreen S., Grauls G., Bruggeman C., and Stassen F. Improved detection and quantification of mouse cytomegalovirus by real-time PCR Virus Res. 98 2003 17 25
19. Kurz S., Steffens H.P., Mayer A., Harris J.R., and Reddehase M.J. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs J. Virol. 71 1997 2980 2987
20. Sinclair J., and Sissons P. Latent and persistent infections of monocytes and macrophages Intervirology 39 1996 293 301
21. Hendrix M.G.R., Bruggeman C.A., and van Boven C.P.A. Alterations of the functional state of peritoneal macrophages during rat cytomegalovirus infection in vivo FEMS Microbiol. Lett. 33 1986 111 115
22. Mocarski E.S. Cytomegaloviruses and their replication Fields B.N. Knipe D.M. Howley P.M. Fields Virology 1996 Lippincott-Raven Publishers Philadelphia 2447 2492
23. Lucin P., Jonjic S., Messerle M., Polic B., Hengel H., and Koszinowski U.H. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor J. Gen. Virol. 75 1994 101 110
24. Fish K.N., Britt W., and Nelson J.A. A novel mechanism for persistence of human cytomegalovirus in macrophages J. Virol. 70 1996 1855 1862
25. Presti R.M., Pollock J.L., DalCanto A.J., Ak O.G., and Virgin H.W. Interferon-gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels J. Exp. Med. 188 1998 577 588
26. Pomeroy C., Delong D., Clabots C., Riciputi P., and Filice G.A. Role of interferon-gamma in murine cytomegalovirus infection J. Lab. Clin. Med. 132 1998 124 133
27. Mastroeni P., Clare S., and Khan S. Interleukin-18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium Infect. Immun. 67 1999 478 483
28. Kawakami K., Qureshi M.H., Zhang T., Okamura H., Kurimoto M., and Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production J. Immunol. 159 1997 5528 5534
29. Munder M., Mallo M., Eichmann K., and Modolell M. Murine macrophages secrete interferon-gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation J. Exp. Med. 187 1998 2103 2108
30. Golab J., Zagozdzon B., Stoklosal T., Kaminski R., Kozar K., and Jakobisiak M. Direct stimulation of macrophages by IL-12 and IL-18 - a bridge too far? Immunol. Lett. 72 2000 153 157
31. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules Annu. Rev. Immunol. 15 1997 821 850
32. Pieters J. MHC class II-restricted antigen processing and presentation Adv. Immunol. 75 2000 159 208
33. Jenkins M.K., Khoruts A., and Ingulli E. In vivo activation of antigen-specific CD4 T cells Annu. Rev. Immunol. 19 2001 23 45
34. Kuchroo V.K., Das M.P., and Brown J.A. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy Cell 80 1995 707 718
35. Yang Y., and Wilson J.M. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40 Science 273 1996 1862 1864
36. Schonbeck U., and Libby P. CD40 signaling and plaque instability Circ. Res. 89 2001 1092 1103
37. Jonasson L., Holm J., Skalli O., Gabbiani G., and Hansson G.K. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis J. Clin. Invest. 76 1985 125 131
38. Nicoletti A., Caligiuri G., Tornberg I., Kodama T., Stemme S., and Hansson G.K. The macrophage scavenger receptor type A directs modified proteins to antigen presentation Eur. J. Immunol. 29 1999 512 521
39. Lee T.S., Yen H.C., Pan C.C., and Chau L.Y. The role of interleukin-12 in the development of atherosclerosis in ApoE-deficient mice Arterioscler. Thromb. Vasc. Biol. 19 1999 734 742
40. Mallat Z., Corbaz A., and Scoazec A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability Circulation 104 2001 1598 1603
41. /- mice Am. J. Pathol. 157 2000 1819 1824
42. Buono C., Come C.E., Stavrakis G., Maguire G.F., Connelly P.W., and Lichtman A.H. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse Arterioscler. Thromb. Vasc. Biol. 23 2003 454 460